BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 31295467)

  • 1. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
    Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
    Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.
    Sarkar S; Jun S; Rellick S; Quintana DD; Cavendish JZ; Simpkins JW
    Brain Res; 2016 Sep; 1646():139-151. PubMed ID: 27235866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Xu Y; Chen P; Wang X; Yao J; Zhuang S
    Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Decline and Modulation of Alzheimer's Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons.
    Barbato C; Giacovazzo G; Albiero F; Scardigli R; Scopa C; Ciotti MT; Strimpakos G; Coccurello R; Ruberti F
    Mol Neurobiol; 2020 Jul; 57(7):3183-3194. PubMed ID: 32504417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
    Lu Y; Tan L; Wang X
    Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    Chum PP; Hakim MA; Behringer EJ
    J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a knockout attenuates cognitive deficits in APP/PS1 mice through inhibition of the amyloidogenic processing of APP.
    Jian C; Lu M; Zhang Z; Liu L; Li X; Huang F; Xu N; Qin L; Zhang Q; Zou D
    Life Sci; 2017 Aug; 182():104-111. PubMed ID: 28533191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Hu YR; Xing SL; Chen C; Shen DZ; Chen JL
    J Integr Med; 2019 Nov; 17(6):404-409. PubMed ID: 31548147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer's Disease Pathology Precursors.
    Bonds JA; Shetti A; Bheri A; Chen Z; Disouky A; Tai L; Mao M; Head BP; Bonini MG; Haus JM; Minshall RD; Lazarov O
    J Neurosci; 2019 Oct; 39(43):8576-8583. PubMed ID: 31527120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
    Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
    Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
    Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
    CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.